Dr. Melody Cobleigh MD
USINFO | 2013-11-28 14:28

Medical Oncologist

Contact Information
1725 W Harrison St
Suite 1010
Chicago, IL 60612
Phone: (312) 942-5904

Specialty & Clinical Interests
Medical Oncologist: General Oncology

Hospital Affiliation
Rush University Medical Center
Education & Medical Training
Rush University Medical Center
Residency, Internal Medicine, 1976 - 1976
Rush University Medical Center
Residency, Internal Medicine, 1977 - 1979
Indiana University School of Medicine
Fellowship, Hematology, 1979 - 1981
Rush Medical College
Class of 1975

Certifications & Licensure
American Board of Internal Medicine
Certified 2014 years in Internal Medicine
American Board of Internal Medicine
Certified 2014 years in Medical Oncology
IL State Medical License
Active through 2014

Awards, Honors & Recognition
CMS Stage 1 2012, Centers for Medicare & Medicaid Services
2012

Publications & Presentations
HER2-directed treatment of metastatic breast cancer: unanswered questions.
Rao, R.,Cobleigh, M.
Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial.
Schneider, B. P.,Gray, R. J.,Radovich, M.,Shen, F.,Vance, G.,Li, L.,Jiang, G.,Miller, K. D.,Gralow, J. R.,Dickler, M. N.,Cobleigh, M. A.,Perez, E. A.,Shenkier, T. N.,Vang Nielsen, K.,Müller, S.,Thor, A.,Sledge, G. W.,Sparano, J. A.,Davidson, N. E.,Badve, S. S.
Predictors of lymph node metastasis in T1 breast carcinoma, stratified by patient age.
Orucevic, A., Reddy, V. B., Bloom, K. J., Bitterman, P., Magi-Galluzzi, C., Oleske, D. M., Phillips, M., Gould, V. E., Cobleigh, M., Wick, M. R., Gattuso, P.
 
 

美闻网---美国生活资讯门户
©2012-2014 Bywoon | Bywoon